Categorized | Stock Profiles

CSOC Caduceus Software Systems


Share Button

Caduceus Software Systems Corp (CSOC)

csoc

 

Symbol:                               CSOC.OB

 

Outstanding Shares:       275.8M

Float:                                          155.8M

 

Caduceus Software Systems Corp (CSOC) is a healthcare software company headquartered in United Kingdom, primarily in Birmingham, England, that has created a simple, all-in-one solution specifically licensed for healthcare practitioners to ease the process of Electronic Health Records (EMR) and Electronic Medical Billing (EMB).

CSOC’s software, Caduceus MMS, is ideal for any of the 12 million medical professionals in the U.S who is in need of organizing patient files, medical history, billing, insurance and remittance and other day to day business routine. Furthermore, CSOC’s software is also coupled with a large and diverse library of illnesses, conditions, treatments, medications, and diagnoses along with the appropriate International Classification Disease (ICD) codes. CSOC’s characteristics are different than other EMR ad EMB software because CSOC will customize itself according to the clients’ needs. Other software currently in the market will provide too many “functions” that do not meet the clients’ expectations and consequently cost the client both time and money. CSOC eliminates this error and will allow practitioners to pick and choose what elements will be added to the platform.

In order to properly accommodate the wants and needs of its clients, CSOC has partnered with an Indiana software advisor, Sygnit Corp., who will assist CSOC in securing the programming and technical goals of CSOC. In addition, CSOC will receive assistance in targeting CSOC’s marketing and sale endeavor that has recently begun in North America, primarily in the state of Indiana.

 

Website:  www.caduceusco.com

 

Get more info on CSOC by Getting On our FREE Email List:

This post was written by:

- who has written 203 posts on StockRockandRoll.


Contact the author

Comments are closed.


© 2019 MJ Capital, LLC | All rights reserved